NEW YORK (GenomeWeb) – Luminex reported after the close of the market on Monday that its third quarter revenues were down 2 percent year over year, driven in part by a delay in the timing of customer orders that closed a few days after the end of the quarter.

For the quarter ended Sept. 30, the molecular diagnostics company reported revenues of $72.4 million, down from $74.1 million in the year-ago quarter, and short of the average Wall Street estimate for revenues of $74.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.